KR

Karunakar Reddy Yeruva

Active Director Managing Director DIN 10713738
DIN 10713738 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Karunakar Reddy Yeruva

Data last updated:

Karunakar Reddy Yeruva is a Managing Director at Rovix Nutrition Private Limited (since 2024). The company operates in Pharma.

DIN 10713738
Primary Designation Managing Director
Industry Pharma
First Appointment 21 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rovix Nutrition Private Limited U46497TS2024PTC187719
Managing Director21 Jul 20242024Active

Board colleagues of Karunakar Reddy Yeruva

NameDINCompanyDesignation
Tumma Lourdu Mary10713739Rovix Nutrition Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rovix Nutrition Private Limited
Premium access

Shareholding and investment profile for Karunakar Reddy Yeruva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karunakar Reddy Yeruva

Karunakar Reddy Yeruva currently holds 1 directorship: Rovix Nutrition Private Limited (Managing Director, since 21 Jul 2024).

Karunakar Reddy Yeruva was first appointed on 21 Jul 2024 as Managing Director at Rovix Nutrition Private Limited.

The current boards of Karunakar Reddy Yeruva's companies include Tumma Lourdu Mary (Rovix Nutrition Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available